iodine I 131 monoclonal antibody 3F8

RADIATION4 trials

Sponsors

Memorial Sloan Kettering Cancer Center

Conditions

Brain and Central Nervous System TumorsIntraocular MelanomaLung CancerMelanoma (Skin)Metastatic CancerNeuroblastomaOvarian CancerRetinoblastoma

Phase 1

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

CompletedNCT00003022

Memorial Sloan Kettering Cancer CenterBrain and Central Nervous System Tumors, Intraocular Melanoma, Lung Cancer +4

Start: 1997-04-30End: 2005-01-31Updated: 2013-07-03

Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma

CompletedNCT00450827

Memorial Sloan Kettering Cancer CenterNeuroblastoma

Start: 2006-08-31End: 2015-08-31Updated: 2015-09-28

Phase 2

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

CompletedNCT00445965

Memorial Sloan Kettering Cancer CenterBrain and Central Nervous System Tumors, Intraocular Melanoma, Lung Cancer +7

Start: 2006-01-31End: 2023-02-01Updated: 2024-04-04

Unknown Phase

Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma

CompletedNCT00058370

Memorial Sloan Kettering Cancer CenterBrain and Central Nervous System Tumors

Start: 2003-02-28End: 2019-06-30Updated: 2020-05-11